# Francois Vigneault
Principales episodios de podcast
Actualizado:
Top podcast episodes featuring francois vigneault.
Bookwork
This episode discusses the works of Black sci-fi author QJ Zephyr & Canadian graphic novelist Francois Vigneault. Plus we check-in with Chicago’s Philmore Greene for insights on his track ‘TIME’ featuring Skyzoo.
Guests:
• Miki Vale, playwright https://mikivalethemc.com/
• King Dice http://www.…
Episode 23-21 New Ways to Treat What Ails Us
On this week’s Tech Nation, Moira speaks with Dr. Francois Vigneault, Co-Founder and CEO of Shape Therapeutics, talks about how they’re engineering mRNA to address Parkinson’s and Alzheimer’s. Then, Dr. Pail Peter Tak, CEO of Candel Therapeutics is using immuno-oncology treatments to go after solid…
AI Three Different Ways to a New Drug??? Dr. Francois Vigneault, Co-Founder & CEO Shape Therapeutics
Discover the limitless potential of mRNA engineering as Dr. Francois Vigneault, Co-Founder and CEO of Shape Therapeutics, discusses their groundbreaking work in using mRNA to address genetic mutations in diseases like Parkinson's and Alzheimer's, offering hope for effective treatments and preventio…
The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault
We love to hear from our listeners. Send us a message.
Dr. Francois Vigneault, Co-Founder, President, and CEO at Shape Therapeutics joins Cell & Gene: The Podcast's Erin Harris to discuss how RNA technologies are shaping the future of gene therapy. They also discuss AI's role in gene therapy as wel…
Episode 24-44 New Ways to Treat What Ails Us
On this week’s Tech Nation, Moira speaks with Dr Francois Vigneault, Co-Founder and CEO of Shape Therapeutics, who talks about how they’re engineering mRNA to address Parkinson’s and Alzheimer’s. Then, Dr. Pail Peter Tak, CEO of Candel Therapeutics, uses immuno-oncology treatments to treat solid tu…
Episode 523: Episode 23-21 New Ways to Treat What Ails Us
On this week’s Tech Nation, Moira speaks with Dr. Francois Vigneault, Co-Founder and CEO of Shape Therapeutics, talks about how they’re engineering mRNA to address Parkinson’s and Alzheimer’s. Then, Dr. Pail Peter Tak, CEO of Candel Therapeutics is using immuno-oncology treatments to go after solid…
Episode 523: Episode 23-21 New Ways to Treat What Ails Us
On this week’s Tech Nation, Moira speaks with Dr. Francois Vigneault, Co-Founder and CEO of Shape Therapeutics, talks about how they’re engineering mRNA to address Parkinson’s and Alzheimer’s. Then, Dr. Pail Peter Tak, CEO of Candel Therapeutics is using immuno-oncology treatments to go after solid…
#34 Power laws and T-cell receptors with Kristina Grigaityte
An αβ T-cell receptor is composed of two highly variable protein chains, the α
chain and the β chain. However, based only on bulk DNA or RNA sequencing it is
impossible to determine which of the α chain and β chain sequences were paired
in the same receptor.
In this episode, Kristina Grigaityte t…
MOTOR DE BÚSQUEDA DE PODCAST
Puede utilizar nuestro sitio web para buscar podcasts de3,825,055y episodios de195,811,027por personas, lugares o temas.
Invertir en conocimiento ofrece el mejor rendimiento, por eso escucho podcasts.
‐ Benjamin "Llamacorn" Franklin
EDITAR
Gracias por ayudar a mantener actualizada la base de datos de podcasts.
